Analyst Activity – Aegis Reiterates Buy on Heron Therapeutics (NASDAQ:HRTX)

ME Staff
-
0

Analyst Ratings For Heron Therapeutics (NASDAQ:HRTX)

Today, Aegis reiterated its Buy rating on Heron Therapeutics (NASDAQ:HRTX) with a price target of $33.00.

There are 10 buy ratings on the stock.

The current consensus rating on Heron Therapeutics (NASDAQ:HRTX) is Buy (Score: 3.00) with a consensus target price of $33.13 per share, a potential 104.48% upside.

Some recent analyst ratings include

  • 7/18/2017-Aegis Reiterated Rating of Buy.
  • 7/14/2017-Jefferies Group LLC Reiterated Rating of Buy.
  • 6/26/2017-Cantor Fitzgerald Reiterated Rating of Overweight.
  • 5/26/2017-Cowen and Company Reiterated Rating of Buy.
  • 5/12/2017-Noble Financial Reiterated Rating of Buy.
  • 2/27/2017-Needham & Company LLC initiated coverage with a Buy rating.


  • On 4/24/2017 Kimberly Manhard, VP, sold 21,542 with an average share price of $15.33 per share and the total transaction amounting to $330,238.86. View SEC Filing
  • On 1/19/2017 Kevin C Tang, Director, bought 2,459,016 with an average share price of $12.20 per share and the total transaction amounting to $29,999,995.20. View SEC Filing
  • On 8/10/2016 Robert Rosen, Insider, sold 100,000 with an average share price of $23.30 per share and the total transaction amounting to $2,330,000.00. View SEC Filing
  • On 4/21/2016 Robert Rosen, President, sold 200,000 with an average share price of $23.23 per share and the total transaction amounting to $4,646,000.00. View SEC Filing
  • On 6/10/2015 Kevin C Tang, Director, bought 121,212 with an average share price of $24.75 per share and the total transaction amounting to $2,999,997.00. View SEC Filing
  • On 6/2/2015 Kevin C Tang, Director, bought 150,000 with an average share price of $20.62 per share and the total transaction amounting to $3,093,000.00. View SEC Filing
  • On 6/1/2015 Kimberly Manhard, Director, sold 2,708 with an average share price of $21.17 per share and the total transaction amounting to $57,328.36. View SEC Filing

Recent Trading Activity for Heron Therapeutics (NASDAQ:HRTX)
Shares of Heron Therapeutics closed the previous trading session at 16.80 up +0.60 3.70% with 1,717,997 shares trading hands.